The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
The findings contradict prior research that utilized the same software, experts involved in the research noted. This could be due to out-of-distribution data for the DL software, which could impair its performance.
Recent evidence confirms that interventional radiology produces solid clinical outcomes while beating surgery on the cost-effectiveness of numerous procedures.
Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists.
In comparison to a cohort of individuals who were unaffected by either condition, the differences in brain stem volume were found to be significant, according to a paper published recently in Frontiers in Neuroscience.
A new experimental study focused on how different sex hormones can affect the heart's ability to properly pump blood. Estradiol, the most active form of estrogen, stood out as a hormone that requires additional research.
